T. Rowe Price Associates’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.7M | Sell |
2,193,873
-5,548
| -0.3% | -$77.7K | ﹤0.01% | 859 |
|
|
2025
Q1 | $41M | Buy |
2,199,421
+193,644
| +10% | +$3.61M | 0.01% | 779 |
|
|
2024
Q4 | $22.6M | Buy |
2,005,777
+694,761
| +53% | +$7.82M | ﹤0.01% | 966 |
|
|
2024
Q3 | $15.5M | Buy |
1,311,016
+1,258,648
| +2,403% | +$14.9M | ﹤0.01% | 1047 |
|
|
2024
Q2 | $410K | Buy |
52,368
+7,519
| +17% | +$58.9K | ﹤0.01% | 2272 |
|
|
2024
Q1 | $223K | Sell |
44,849
-1,024,897
| -96% | -$5.1M | ﹤0.01% | 2564 |
|
|
2023
Q4 | $9.21M | Sell |
1,069,746
-55,795
| -5% | -$480K | ﹤0.01% | 1112 |
|
|
2023
Q3 | $7.81M | Sell |
1,125,541
-181,746
| -14% | -$1.26M | ﹤0.01% | 1103 |
|
|
2023
Q2 | $7.52M | Sell |
1,307,287
-70,170
| -5% | -$404K | ﹤0.01% | 1116 |
|
|
2023
Q1 | $8.76M | Sell |
1,377,457
-386,104
| -22% | -$2.46M | ﹤0.01% | 1086 |
|
|
2022
Q4 | $20.7M | Sell |
1,763,561
-391,084
| -18% | -$4.6M | ﹤0.01% | 904 |
|
|
2022
Q3 | $25.5M | Sell |
2,154,645
-6,651,242
| -76% | -$78.8M | ﹤0.01% | 834 |
|
|
2022
Q2 | $100M | Buy |
8,805,887
+236,652
| +3% | +$2.7M | 0.01% | 658 |
|
|
2022
Q1 | $96.2M | Buy |
8,569,235
+654,309
| +8% | +$7.35M | 0.01% | 743 |
|
|
2021
Q4 | $111M | Sell |
7,914,926
-549,331
| -6% | -$7.72M | 0.01% | 729 |
|
|
2021
Q3 | $135M | Buy |
8,464,257
+587,020
| +7% | +$9.38M | 0.01% | 675 |
|
|
2021
Q2 | $177M | Buy |
7,877,237
+47,690
| +0.6% | +$1.07M | 0.02% | 599 |
|
|
2021
Q1 | $165M | Buy |
+7,829,547
| New | +$165M | 0.02% | 608 |
|